ArticleExploration of medicine2025
Solid tumor rejection using personalized incompatible human leukocyte antigen (HLA) and blood group ABH antigens.
Apostolos P Georgopoulos et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it